335 related articles for article (PubMed ID: 19010317)
1. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.
Woo HM; Kim KM; Choi MH; Jung BH; Lee J; Kong G; Nam SJ; Kim S; Bai SW; Chung BC
Clin Chim Acta; 2009 Feb; 400(1-2):63-9. PubMed ID: 19010317
[TBL] [Abstract][Full Text] [Related]
2. RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer.
Chen Y; Zhang R; Song Y; He J; Sun J; Bai J; An Z; Dong L; Zhan Q; Abliz Z
Analyst; 2009 Oct; 134(10):2003-11. PubMed ID: 19768207
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.
Wu H; Xue R; Lu C; Deng C; Liu T; Zeng H; Wang Q; Shen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3111-7. PubMed ID: 19716777
[TBL] [Abstract][Full Text] [Related]
4. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
Chen J; Wang W; Lv S; Yin P; Zhao X; Lu X; Zhang F; Xu G
Anal Chim Acta; 2009 Sep; 650(1):3-9. PubMed ID: 19720165
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
6. Urinary hydrophilic and hydrophobic metabolic profiling based on liquid chromatography-mass spectrometry methods: Differential metabolite discovery specific to ovarian cancer.
Chen J; Zhou L; Zhang X; Lu X; Cao R; Xu C; Xu G
Electrophoresis; 2012 Nov; 33(22):3361-9. PubMed ID: 23109122
[TBL] [Abstract][Full Text] [Related]
7. Discovery of safety biomarkers for atorvastatin in rat urine using mass spectrometry based metabolomics combined with global and targeted approach.
Kumar BS; Lee YJ; Yi HJ; Chung BC; Jung BH
Anal Chim Acta; 2010 Feb; 661(1):47-59. PubMed ID: 20113715
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus.
Li X; Xu Z; Lu X; Yang X; Yin P; Kong H; Yu Y; Xu G
Anal Chim Acta; 2009 Feb; 633(2):257-62. PubMed ID: 19166731
[TBL] [Abstract][Full Text] [Related]
9. Metabolic significance of bisphenol A-induced oxidative stress in rat urine measured by liquid chromatography-mass spectrometry.
Cho SH; Choi MH; Kwon OS; Lee WY; Chung BC
J Appl Toxicol; 2009 Mar; 29(2):110-7. PubMed ID: 18980270
[TBL] [Abstract][Full Text] [Related]
10. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
[TBL] [Abstract][Full Text] [Related]
11. Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling.
Zhang T; Wu X; Ke C; Yin M; Li Z; Fan L; Zhang W; Zhang H; Zhao F; Zhou X; Lou G; Li K
J Proteome Res; 2013 Jan; 12(1):505-12. PubMed ID: 23163809
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.
Wu H; Xue R; Dong L; Liu T; Deng C; Zeng H; Shen X
Anal Chim Acta; 2009 Aug; 648(1):98-104. PubMed ID: 19616694
[TBL] [Abstract][Full Text] [Related]
13. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
Zhu C; Liang QL; Hu P; Wang YM; Luo GA
Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
[TBL] [Abstract][Full Text] [Related]
14. Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity.
Song H; Wang L; Liu HL; Wu XB; Wang HS; Liu ZH; Li Y; Diao DC; Chen HL; Peng JS
Oncol Rep; 2011 Aug; 26(2):431-8. PubMed ID: 21567103
[TBL] [Abstract][Full Text] [Related]
15. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry.
Issaq HJ; Nativ O; Waybright T; Luke B; Veenstra TD; Issaq EJ; Kravstov A; Mullerad M
J Urol; 2008 Jun; 179(6):2422-6. PubMed ID: 18433783
[TBL] [Abstract][Full Text] [Related]
16. Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers--a powerful strategy for breast cancer diagnosis.
Silva CL; Passos M; Câmara JS
Talanta; 2012 Jan; 89():360-8. PubMed ID: 22284503
[TBL] [Abstract][Full Text] [Related]
17. Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers.
Slupsky CM; Steed H; Wells TH; Dabbs K; Schepansky A; Capstick V; Faught W; Sawyer MB
Clin Cancer Res; 2010 Dec; 16(23):5835-41. PubMed ID: 20956617
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic profiling of rat serum associated with isoproterenol-induced myocardial infarction using ultra-performance liquid chromatography/time-of-flight mass spectrometry and multivariate analysis.
Zhang HY; Chen X; Hu P; Liang QL; Liang XP; Wang YM; Luo GA
Talanta; 2009 Jul; 79(2):254-9. PubMed ID: 19559874
[TBL] [Abstract][Full Text] [Related]
19. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
Fan L; Zhang W; Yin M; Zhang T; Wu X; Zhang H; Sun M; Li Z; Hou Y; Zhou X; Lou G; Li K
Acta Oncol; 2012 Apr; 51(4):473-9. PubMed ID: 22283470
[TBL] [Abstract][Full Text] [Related]
20. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets.
Zhang AH; Sun H; Han Y; Yan GL; Yuan Y; Song GC; Yuan XX; Xie N; Wang XJ
Anal Chem; 2013 Aug; 85(15):7606-12. PubMed ID: 23845028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]